Skip to main content

previous disabled Page of 7
and
  1. No Access

    Article

    Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study)

    This randomized phase II study explored the superiority of trastuzumab plus S-1 plus cisplatin (SP) over SP alone as neoadjuvant chemotherapy (NAC) for HER2-positive resectable gastric cancer with extensive ly...

    Masanori Tokunaga, Nozomu Machida, Junki Mizusawa, Seiji Ito in Gastric Cancer (2024)

  2. No Access

    Article

    A patient alive without disease 32 months after conversion surgery following lenvatinib treatment for hepatocellular carcinoma with a tumor thrombus originating in the middle hepatic vein and reaching the right atrium via the suprahepatic vena cava: a case report

    Conversion surgery for initially unresectable hepatocellular carcinoma appears to be increasing in incidence since the advent of new molecular target drugs and immune checkpoint inhibitors; however, reports on...

    Yu Gyoda, Hirofumi Ichida, Fumihiro Kawano in Clinical Journal of Gastroenterology (2024)

  3. No Access

    Article

    Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer

    We previously showed that daily nutritional intervention with an oral elemental diet (ED) at 300 kcal/day for 6–8 weeks postoperatively decreased the percentage of body weight loss (%BWL), and that the effect ...

    Kazuhiro Nishikawa, Yutaka Kimura in International Journal of Clinical Oncology (2024)

  4. No Access

    Article

    Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902)

    Although there is insufficient evidence for the treatment of older patients with advanced gastric cancer, fluorouracil combined with platinum chemotherapy has been recognized as a standard first-line treatment...

    Tomono Kawase, Hiroshi Imamura in International Journal of Clinical Oncology (2024)

  5. Article

    Open Access

    Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study

    Capecitabine plus oxaliplatin (CapeOX) is a standard treatment option for advanced gastric cancer (AGC). We conducted a prospective multicenter phase II study to evaluate the efficacy and safety of CapeOX as a fi...

    Ryohei Kawabata, Keisho Chin, Daisuke Takahari, Hisashi Hosaka in Gastric Cancer (2023)

  6. No Access

    Article

    A Novel Surgical Technique for Double Flap Reconstruction Using a Circular Stapler After Laparoscopic Proximal Gastrectomy

    Yoshitomo Yanagimoto, Takeshi Omori, Kazuki Odagiri in Journal of Gastrointestinal Surgery (2023)

  7. Article

    Effect of the number of cycles of docetaxel + S-1 therapy on long-term survival in adjuvant chemotherapy for stage III gastric cancer. A pooled analysis of the OGSG0604 and OGSG1002 trials

    S-1 plus docetaxel (DS) therapy followed by S-1 is the standard of care in Japan in postoperative adjuvant chemotherapy for stage III gastric cancer, but long-term survival and the number of DS cycles required...

    Yutaka Kimura, Hisato Kawakami, Shigeyuki Tamura, Kazumasa Fujitani in Gastric Cancer (2023)

  8. No Access

    Article

    Analysis of the risk factors for osteoporosis and its prevalence after gastrectomy for gastric cancer in older patients: a prospective study

    Osteoporosis leads to fragility fractures and is a major public health problem. We conducted this study to analyze the prevalence of and risk factors for osteoporosis after gastrectomy in older patients.

    Ryohei Kawabata, Tsuyoshi Takahashi, Yurina Saito, Rie Nakatsuka in Surgery Today (2023)

  9. Article

    Open Access

    Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study

    Fibroblast growth factor receptor 2 (FGFR2) and human epidermal growth factor receptor 2 (HER2) proteins are both molecular targets for cancer therapy. The objective of this study was to evaluate the expressio...

    Hisateru Yasui, Atsushi Takeno, Hiroki Hara in International Journal of Colorectal Disease (2022)

  10. No Access

    Article

    Contrast-enhanced ultrasonographic findings of non-occlusive mesenteric ischemia: a case series

    Diagnosis of non-occlusive mesenteric ischemia (NOMI) is difficult, with diagnostic imaging being mainly performed using angiography or contrast-enhanced computed tomography. Contrast-enhanced ultrasonography ...

    Hiroshi Imamura, Jiro Hata, Tamako Takata in Abdominal Radiology (2022)

  11. No Access

    Article

    Parachute technique for portal vein reconstruction during pancreaticoduodenectomy with portal vein resection in patients with pancreatic head cancer

    The most appropriate venous reconstruction method remains debatable when a long section of portal vein (PV) and/or superior mesenteric vein (SMV) must be resected in patients undergoing a pancreaticoduodenecto...

    Shoichi Irie, Ryuji Yoshioka, Hiroshi Imamura in Langenbeck's Archives of Surgery (2022)

  12. No Access

    Article

    Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701

    To compare irinotecan-alone, paclitaxel-alone, and each combination chemotherapy with S-1 in patients with advanced gastric cancer (AGC) that is refractory to S-1 or S-1 plus cisplatin (SP).

    Tomono Kawase, Hiroshi Imamura, Masahiro Goto in International Journal of Clinical Oncology (2021)

  13. Article

    Open Access

    Left paraduodenal hernia treated by single-incision laparoscopic surgery: a case report

    Paraduodenal hernia is a rare internal hernia which accounts for only 1% of all intestinal hernias. There have been limited reported cases of paraduodenal hernia treated by laparoscopic surgery. We report a ca...

    Noboru Hasegawa, Hiroshi Takeyama, Yozo Suzuki, Shingo Noura in Surgical Case Reports (2021)

  14. Article

    Open Access

    A case report of fibrolamellar hepatocellular carcinoma, with particular reference to preoperative diagnosis, value of molecular genetic diagnosis, and cell origin

    Fibrolamellar hepatocellular carcinoma (FL-HCC) is a liver tumor that occurs almost exclusively in young adults without underlying liver disease. In spite of its distinct clinical characteristics and specific ...

    Atsushi Takahashi, Hiroshi Imamura, Ryota Ito, Fumihiro Kawano in Surgical Case Reports (2021)

  15. Article

    Oral nutritional supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3, multicenter, open-label randomized controlled trial

    Body weight loss (BWL) after gastrectomy is associated with not only a deteriorated quality of life but also a poor prognosis. Oral nutritional supplements (ONS) may be used to minimize BWL, which is observed ...

    Yasuhiro Miyazaki, Takeshi Omori, Kazumasa Fujitani, Junya Fujita in Gastric Cancer (2021)

  16. No Access

    Article

    Accuracy of Modern Clinical Risk Score Including RAS Status Changes Based on Whether Patients Received Perioperative Chemotherapy for Colorectal Liver Metastases

    A modified Fong clinical score (m-Fong CS) that includes the RAS mutation status has recently been proposed and offered an improved survival stratification of patients who undergo surgery and systemic chemothe...

    Yoshinori Takeda, Yoshihiro Mise, Masaru Matsumura in World Journal of Surgery (2021)

  17. No Access

    Article

    Resection of a large gastrointestinal stromal tumor in the stomach after imatinib treatment in a 90-year-old patient

    A 90-year-old woman presented with a 1-month history of progressive abdominal fullness. Contrast computed tomography (CT) showed a large 17-cm mass located adjacent to the antrum of the stomach without metasta...

    Aya Sugimoto, Tsutomu Nishida, Masashi Hirota in Clinical Journal of Gastroenterology (2021)

  18. Article

    Open Access

    Laparoscopic cholecystectomy after endoscopic trans-papillary gallbladder stenting for acute cholecystitis: a pilot study of surgical feasibility

    Percutaneous transhepatic gallbladder drainage (PTGBD) is indicated for patients with acute cholecystitis (AC) who are not indicated for urgent surgery, but external tubes reduce quality of life (QOL) while wa...

    Fumihiro Kawano, Ryuji Yoshioka, Yu Gyoda, Hirofumi Ichida, Tomoya Mizuno in BMC Surgery (2021)

  19. Article

    Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastric cancer

    We had previously reported that surgical palliation could maintain quality of life (QOL) while improving solid food intake among patients with malignant gastric outlet obstruction (GOO) caused by advanced gast...

    Masanori Terashima, Kazumasa Fujitani, Masahiko Ando, Kentaro Sakamaki in Gastric Cancer (2021)

  20. Article

    Open Access

    A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302)

    For unresectable or recurrent advanced gastric adenocarcinoma (AGC), tri-weekly administration of nanoparticle albumin-bound paclitaxel (nab-PTX) at 260 mg/m2 achieved a response rate of 27.8% in a phase II trial...

    Shigeyuki Tamura, Hirokazu Taniguchi in International Journal of Clinical Oncology (2020)

previous disabled Page of 7